Pacira Pharmaceuticals‘ (NASDAQ: PCRX) Exparel provides pain relief after surgery, and that’s reducing the need to prescribe opiates. The company’s studying Exparel’s use in multiple indications, and that could make it a bigger alternative to oral opioids. Can its use help address the opioid crisis?
In this clip from The Motley Fool’s Industry Focus: Healthcare podcast, analyst Kristine Harjes is joined by Todd Campbell to discuss Exparel and its future.
A full transcript follows the video.